Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Big Data Hub
MAY 6, 2024
For instance, the FDA released guidance in November 2020 titled, “Enhancing the diversity of clinical trial populations.” The FDA’s 2020 guidance emphasized expanding eligibility criteria and reducing unnecessary exclusions. Recognizing this gap, regulators emphasize the importance of greater diversity.
Let's personalize your content